E Fund Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Sell |
13,887
-967
| -7% | -$67.6K | 0.05% | 174 |
|
|
2025
Q1 | $1.09M | Buy |
14,854
+7,934
| +115% | +$583K | 0.05% | 160 |
|
|
2024
Q4 | $453K | Buy |
6,920
+1,488
| +27% | +$97.5K | 0.02% | 240 |
|
|
2024
Q3 | $423K | Buy |
5,432
+454
| +9% | +$35.4K | 0.02% | 215 |
|
|
2024
Q2 | $388K | Buy |
4,978
+107
| +2% | +$8.35K | 0.02% | 200 |
|
|
2024
Q1 | $330K | Sell |
4,871
-141
| -3% | -$9.55K | 0.02% | 266 |
|
|
2023
Q4 | $338K | Sell |
5,012
-484
| -9% | -$32.6K | 0.02% | 218 |
|
|
2023
Q3 | $372K | Buy |
5,496
+1,076
| +24% | +$72.8K | 0.03% | 179 |
|
|
2023
Q2 | $316K | Sell |
4,420
-950
| -18% | -$67.9K | 0.03% | 211 |
|
|
2023
Q1 | $373K | Sell |
5,370
-434
| -7% | -$30.1K | 0.03% | 191 |
|
|
2022
Q4 | $394K | Buy |
5,804
+12
| +0.2% | +$815 | 0.03% | 183 |
|
|
2022
Q3 | $318K | Buy |
5,792
+274
| +5% | +$15K | 0.03% | 226 |
|
|
2022
Q2 | $365K | Buy |
5,518
+91
| +2% | +$6.02K | 0.03% | 201 |
|
|
2022
Q1 | $360K | Buy |
+5,427
| New | +$360K | 0.01% | 164 |
|